TranSenda

BioClinica Reports Flat Earnings, Adjusts 2010 EPS Guidance

Wednesday, May 5, 2010 01:07 PM

BioClinica’s first quarter 2010 earnings were flat compared with the same period 2009, with service revenues of $14.7 million. First quarter revenues last year were $14.5 million. Net income was $711,000, or $0.05 per diluted share, compared with $786,000, or $0.05 per diluted share for Q1 2009.

More... »


BioClinica Buys TranSenda, Adds CTMS to Service Offerings

Monday, April 5, 2010 06:52 AM

BioClinica continued to grow its burgeoning eClinical division with the acquisition of clinical trial management software (CTMS) company TranSenda for an estimated $2.5 million.

More... »


CWWeekly July 7th Issue

Friday, July 11, 2008 10:41 AM

Top News

More... »

CenterWatch Data Library
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs